325.9K
Downloads
233
Episodes
The Cardiovascular CME podcast is a new educational offering from Mayo Clinic, featuring content geared towards physicians, physician assistants, and nurse practitioners who are interested in exploring a multitude of cardiology-related topics. Tune in and subscribe to explore today’s most pressing cardiology topics with your colleagues at Mayo Clinic and gain valuable insights that can be directly applied to your practice. No CME credit offered for podcast episodes at this time.
Episodes
Tuesday May 07, 2024
ICI Myocarditis
Tuesday May 07, 2024
Tuesday May 07, 2024
ICI Myocarditis
Guest: Joerg Herrmann, M.D.
Hosts: Sharonne Hayes, M.D.
At the end of this recording, the listener will have an understanding of the use of immune checkpoint inhibitors (ICIs) and their cardiovascular side effects, which include myocarditis, heart failure, and acute coronary events. Challenges in diagnosis and treatment of these cardiovascular events will be discussed.
Topics Discussed:
- What are immune checkpoint inhibitors (ICIs) and for which diseases are they used?
- What are the most common side effects of ICIs to be aware of, especially cardiovascular side effects for our audience?
- How do you diagnose ICI myocarditis? What are the caveats?
- How do you treat ICI myocarditis? Can you resume ICI therapy once resolved?
- What about other CV side effects with ICI therapy? Easy to recognize, easy to manage?
Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.
LinkedIn: Mayo Clinic Cardiovascular Services
Cardiovascular Education App:
The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today!
No CME credit offered for this episode.
Podcast episode transcript found here.